超声评估颅型和大血管型巨细胞动脉炎疾病活动性的前瞻性随访研究
前瞻性随访新发颅型和大血管型巨细胞动脉炎患者,在基线及8周、24周、15个月评估血管超声评分的变化敏感性和区分能力。含颞动脉的复合超声评分从第8周起变化敏感;OGUS显示较大变化幅度,多个颞动脉评分区分缓解与复发的曲线下面积≥0.8。作者建议OGUS作为临床试验中评估治疗反应的结局指标,超声评分区分缓解与复发的能力令人鼓舞,应进一步探索。
要点
- 基线超声阳性44/47例,其中颞动脉72%、大血管72%。
- 含颞动脉的复合超声评分从第8周起变化敏感,大血管反应差。
- 6例临床缓解患者出现新腋动脉超声病变。
核心结论
- 作者建议OGUS作为临床试验中评估治疗反应的结局测量指标。
- 超声评分区分缓解与复发的能力令人鼓舞,应进一步探索。
研究设计与样本
- 前瞻性队列随访研究,纳入新发颅型和大血管型巨细胞动脉炎患者47例。
- 在基线及随访8周、24周和15个月进行颞动脉、颈动脉和腋动脉超声,评估晕征并测量内膜中层复合体(IMC)。
- 计算最大IMC、最大晕IMC、IMC总和、晕IMC总和、平均IMC、晕计数和Southend晕评分,并获取暂定OMERACT超声评分OGUS。
主要发现
- 基线超声阳性44/47例(72%颞动脉,72%大血管)。
- 所有含颞动脉的复合超声评分从第8周起变化敏感。
- 大血管反应差,6例患者 despite 临床缓解出现新腋动脉超声病变。
- OGUS显示较大变化幅度,被认为是受潜在偏倚影响最小的评分。
- 所有基于颞动脉的超声评分与疾病活动性标志物呈中-强相关。
关键数值与推荐
- OGUS、颞动脉晕计数、Southend颞动脉晕评分、颞动脉IMC总和及颞动脉平均IMC区分缓解与复发的曲线下面积≥0.8。
临床怎么用
- 作者建议OGUS作为临床试验中评估治疗反应的结局测量指标。
- 作者认为超声评分区分缓解与复发的能力令人鼓舞,应进一步探索。
局限性
- 大血管对治疗反应差,6例患者 despite 临床缓解出现新腋动脉超声病变。
- 超声评分区分缓解与复发的能力应进一步探索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We evaluated sensitivity to change and discriminative abilities of vascular US scores in disease monitoring in the follow-up of a prospective cohort of new-onset cranial and large-vessel (LV) GCA patients. METHODS: Baseline and follow-up (8 weeks, 24 weeks and 15 months) US of temporal arteries (TA), carotid and axillary arteries (LV) included assessment of halo and measurement of the intima media complex (IMC). Max IMC, max halo IMC, sum IMC, sum halo IMC, mean IMC, halo count and the Southend halo score were calculated. The provisional OMERACT US score, OGUS, was obtained, taking the average of temporal arteries and axillary arteries IMCs divided by their normal cut-off values. RESULTS: Baseline US was positive in 44/47 patients (72% TA, 72% LV). Sensitivity to change of all composite US scores containing TAs was evident by week 8 onward. LVs responded poorly and new axillary US lesions emerged in six patients despite clinical remission. The OGUS showed a large magnitude of change and is considered the score least prone to potential bias. All TA-based US scores showed moderate-strong correlation with disease activity markers. OGUS, TA halo count, Southend TA halo score, TA sum IMC and TA mean IMC showed potential to discriminate remission and relapse with area under the curve ≥0.8. CONCLUSIONS: The OGUS is suggested as an outcome measurement for the assessment of treatment response in clinical trials. The abilities of US scores to discriminate remission and relapse are encouraging and should be further explored.
引用
- Nielsen BD, Therkildsen P, Keller KK, et al. Ultrasonography in the assessment of disease activity in cranial and large-vessel giant cell arteritis: a prospective follow-up study. Rheumatology (Oxford). 2023. PMID: 36651670. doi:10.1093/rheumatology/kead028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。